ENDRA Life Sciences (NDRA) Net Margin (2016 - 2018)

ENDRA Life Sciences has disclosed Net Margin across 3 years of filings, most recently posting 45761.31% for Q1 2018.

• In Q1 2018, Net Margin changed N/A year-over-year to 45761.31%; the TTM figure through Dec 2018 stood at 158669.6% (down 15714041.0% YoY), while the FY2018 annual figure was 158669.6%, down 15714041.0% from the prior year.
• Net Margin retreated to 45761.31% in Q1 2018, from 33498.39% in the prior quarter.
• Over the last five years, Net Margin for NDRA reached as high as 133.61% in Q4 2016 and fell as low as 45761.31% in Q1 2018.
• The 3-year median for Net Margin is 2478.35% (2017), against an average of 16437.67%.
• The widest YoY moves for Net Margin: up 3336478 bps in 2017, down 3336478 bps in 2017.
• A 3-year view of Net Margin shows it stood at 133.61% in 2016, then sank by 24971 bps to 33498.39% in 2017, then sank by 37 bps to 45761.31% in 2018.
• According to Business Quant data, Net Margin over the past three periods registered 45761.31%, 33498.39%, and 316.69% for Q1 2018, Q4 2017, and Q3 2017 respectively.